Intellia Therapeutics, Inc. - NTLA
Sector:
Healthcare
· Industry:
In Vitro & In Vivo Diagnostic Substances
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$2.483B
QoQ value delta ($000)
-$30.23M
(-1.2%)
Implied price effect (QoQ)
-1.73%
Shares
Total shares
149,453,819
QoQ shares delta
+799,756
(+0.54%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (NTLA)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 102 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.